Reactivation of Chagas-Mazza disease during treatment with infliximab

An Bras Dermatol. 2017 Nov-Dec;92(6):899-900. doi: 10.1590/abd1806-4841.20177346.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Chagas Disease / chemically induced*
  • Dermatitis, Exfoliative / drug therapy*
  • Dermatologic Agents / adverse effects*
  • Humans
  • Infliximab / adverse effects*
  • Male
  • Middle Aged
  • Psoriasis / drug therapy*
  • Recurrence
  • Treatment Outcome

Substances

  • Dermatologic Agents
  • Infliximab